Research has shown that papillary tubal hyperplasia may lead to the development of serous cancer in the fallopian tubes, ovaries, and peritoneum. According to numerous studies, opportunistic bilateral salpingectomy significantly reduces the risk of developing ovarian cancer. Recent data proves that radical fimbriectomy involving the tube and fimbrio-ovarian junction lowers ovarian, fallopian, and peritoneal serous cancer incidence. Risk-reducing salpingo-oophorectomy (RRSO) remains the gold-standard in prophylaxis regarding ovarian cancer in carriers of BRCA mutations, other options may exist - radical fimbriectomy which preserves function of the ovaries, observation in dedicated centers, and removal of the ovaries upon menopause.